Logo des Repositoriums
Zur Startseite
  • English
  • Deutsch
Anmelden
  1. Startseite
  2. SuUB
  3. Forschungsdokumente
  4. Climate- conscious prescription of inhaled medications : DEGAM S1-Guideline
 
Zitierlink DOI
10.26092/elib/1765

Climate- conscious prescription of inhaled medications : DEGAM S1-Guideline

Veröffentlichungsdatum
2022-08-29
Autoren
Schmiemann, Guido  
Dörks, Michael  
Zusammenfassung
The health care system is responsible for about 5 % of carbon dioxide (CO2) emis-
sions. The biggest contributor to the carbon footprint caused by ambulatory primary care is the prescription of medications, followed by emissions from transportation (of patients and staff) and heating.
Medication for chronic obstructive airway diseases (inhalers) is of special importance regarding the carbon footprint of the health care sector.
The extent to which these inhalers contribute to climate changes varies depending on their method of functioning.
The two main categories of inhalers are dry powder inhalers and metered-dose inhalers.
Dry powder inhalers (DPIs) contain an active substance in powder form. The active ingre-
dient is released and distributed by inhalation, requiring a sufficiently strong inhale to ensure effective therapy.
In contrast, metered dose inhalers (MDIs) use propellants to transport the active substance
into the deep sections of the lungs.
The chlorofluorocarbons (CFCs) that were used as propellants for MDIs in the past have been largely banned due to their impact on the ozone layer and have been replaced by
hydrofluoroalkanes (fluranes). While these do not damage the ozone layer, they are pow -
erful greenhouse gases. Compared with DPIs, MDIs therefore have more potential to damage the atmosphere (global warming potential - GWP).

This guideline aims to support a shift in prescribing patterns of inhalers to reduce the carbon footprint of the health care system. It addresses those involved in prescribing inhalers and counselling patients with asthma/COPD. This includes doctors and their practice teams as well as pharmacists and other health professionals.
The guideline supports climate-conscious prescription of inhalers by
n summarising existing evidence on the decision between DPIs and MDIs
and explicitly addressing the climate damage caused by propellants.
Schlagwörter
Klimawandel

; 

Arzneimittel

; 

Co2 Fußabdruck
Institution
Universität Bremen  
Fachbereich
Gesundheitswissenschaften
Institute
Institut für Public Health und Pflegeforschung (IPP)  
Dokumenttyp
Bericht, Report
Startseite
1
Endseite
13
Zweitveröffentlichung
Nein
Lizenz
https://creativecommons.org/licenses/by/4.0/
Sprache
Englisch
Dateien
Lade...
Vorschaubild
Name

DEGAM LL Klima VO Englisch S1 kurz RZ 290822.pdf

Size

397 KB

Format

Adobe PDF

Checksum

(MD5):e574cfd6c2883da7ff23ec9fa4d6f8b0

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Datenschutzbestimmungen
  • Endnutzervereinbarung
  • Feedback schicken